Day One Biopharma
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1800 Sierra Point Pkwy Ste 200, Brisbane...Phone Number
(650) 484-0899Website
www.dayonebio.comRevenue
$158.2 MillionStock Symbol
DAWNIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
1
1
2
3
2
About Day One Biopharma
Day One Biopharmaceuticals is committed to leading the development of promising new therapies in children and to improving the standard of care for patients of all ages living with cancer. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop emerging cancer treatments that can help both children and adults living with cancer.Explore more
Day One Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Day One Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Day One Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Day One Biopharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Day One Biopharma is spiking on competitors!
Earning: See what the market has to say on Day One Biopharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Day One Biopharma
Product Launch: Get notified when Day One Biopharma launches new products
Click to see if Day One Biopharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Day One Biopharma has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Day One Biopharma as Masked Content
Find more new buyers
Compare Similar Companies to Day One Biopharma
Compare insights from companies similar to Day One Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Day One Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Day One Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Day One Biopharma.
Day One Biopharma financials insights
Gather financial insights about Day One Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$60M
2021
Series B
$130M
Share Placement
$160M
2024
Other Financing Round
$175M
Day One Biopharma Tech Stack
A closer look at the technologies used by Day One Biopharma
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company, Board of Directors
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Day One Biopharma News & Media
Servier completes the acquisition of Day One Biopharmaceuticals
Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. Transaction also includes a strong oncology pipeline of clinical stage assets in rare cancers with high unmet needs. Transaction represents total equity...Day One (DAWN) Soars 100% on $2.5-Billion Merger
Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) is one of the 10 Stocks Investors Are Watching Closely This Week. Day One soared by 100 percent week-on-week, as investors gobbled up its shares following an acquisition that it is set to be taken private and tendered at a 68 percent upside. In a statement earlier in the week, […]Day One (DAWN) Climbs to 3-Year High on $2.5-Billion Merger
Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) is one of the 10 Stocks to Watch Right Now. Day One soared to a new three-year high on Friday, as investors gobbled up shares following news that it is set to merge with France-based Servier for $2.5 billion. In a joint statement, Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) and Servier […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Day One Biopharma
Sign Up For FreeTo access detailed company insights
Day One Biopharmaceuticals is committed to leading the development of promising new therapies in children and to improving the standard of care for patients of all ages living with cancer. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop emerging cancer treatments that can help both chil... Read More
